Clearmind Medicine Inc. Marks Milestone with First Dosing in AUD Treatment Trial
Clearmind Medicine Inc. has achieved a major milestone in its efforts to combat Alcohol Use Disorder (AUD) with the successful dosing of its innovative CMND-100 treatment in a Phase I/IIa clinical trial.
2 minutes to read